Generate a tailored SOP for Dr. Max Crispin. Improve your application with a focused, well-structured draft.
Max Crispin is a Professor of Glycobiology at the University of Southampton, where he also serves as the Director of the Institute of Life Sciences. He studied Biochemistry at Oriel College, University of Oxford, and completed his doctoral studies at the Scripps Research Institute. Max's research focuses on glycoproteins and their role in the development of antibody therapeutics and viral vaccines, particularly against Human Immunodeficiency Virus (HIV). His laboratory, the Glycoprotein Therapeutics Laboratory, develops vaccine candidates and therapeutic antibodies while examining glycan modifications on proteins that influence immune responses. His research has garnered funding from prominent organizations, including the Bill & Melinda Gates Foundation and the European Union's Horizon 2020 program. In addition to his academic roles, Max has served as an expert witness in high-profile legal cases and is recognized in the Web of Science’s list of highly cited researchers. His contributions to the field have been recognized with several prestigious awards and fellowships, affirming his impact and leadership in glycoscience and immunology.
Institute of Life Sciences, University of Southampton • Southampton, ENG
Oversees research and development focused on glycoprotein engineering and antibody therapeutics.